Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049162470> ?p ?o ?g. }
- W3049162470 endingPage "103066" @default.
- W3049162470 startingPage "103066" @default.
- W3049162470 abstract "The growing insights in the next-generation immunotherapy and the state-of-the-art advancement in targeted-agents significantly improved clinical outcome of cancer patients by pointing towards a unexplored Achilles’ heel. Novel toxicity profiles have been uncovered, representing unmet medical needs. Thus, a panel of expert provide comprehensive pharmacological and clinical evidence, to provide a patient-tailored approach to metabolic adverse events associated with novel anti-cancer treatments. Prompted by the need of a multidisciplinary cooperation, a working group of Associazione Italiana Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD) and Società Italiana Farmacologia (SIF) examined the available literature data. The identification of patient risk profile and the characterization of metabolic effects of novel anti-tumour drugs is clearly a clinical challenge that can be addressed by a multidisciplinary clinical approach. Therefore, this review pinpoints the relevance of the challenging profiling of the patient suffering from dysmetabolic conditions induced by the novel therapeutics in medical oncology." @default.
- W3049162470 created "2020-08-21" @default.
- W3049162470 creator A5003675971 @default.
- W3049162470 creator A5022206145 @default.
- W3049162470 creator A5026404310 @default.
- W3049162470 creator A5031095652 @default.
- W3049162470 creator A5033070927 @default.
- W3049162470 creator A5051648139 @default.
- W3049162470 creator A5056567862 @default.
- W3049162470 creator A5072565919 @default.
- W3049162470 creator A5079098718 @default.
- W3049162470 creator A5083632441 @default.
- W3049162470 creator A5083693387 @default.
- W3049162470 creator A5086984759 @default.
- W3049162470 date "2020-10-01" @default.
- W3049162470 modified "2023-09-27" @default.
- W3049162470 title "Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper" @default.
- W3049162470 cites W1493453469 @default.
- W3049162470 cites W1513785617 @default.
- W3049162470 cites W1676400576 @default.
- W3049162470 cites W1725918626 @default.
- W3049162470 cites W1818904016 @default.
- W3049162470 cites W1964991674 @default.
- W3049162470 cites W1965168280 @default.
- W3049162470 cites W1968234252 @default.
- W3049162470 cites W1987045819 @default.
- W3049162470 cites W2011760199 @default.
- W3049162470 cites W2033870734 @default.
- W3049162470 cites W2035600205 @default.
- W3049162470 cites W2047170687 @default.
- W3049162470 cites W2051725201 @default.
- W3049162470 cites W2057692942 @default.
- W3049162470 cites W2068126251 @default.
- W3049162470 cites W2073352138 @default.
- W3049162470 cites W2097819223 @default.
- W3049162470 cites W2107561358 @default.
- W3049162470 cites W2109653150 @default.
- W3049162470 cites W2126177831 @default.
- W3049162470 cites W2126919962 @default.
- W3049162470 cites W2137631342 @default.
- W3049162470 cites W2140875987 @default.
- W3049162470 cites W2143536481 @default.
- W3049162470 cites W2151507811 @default.
- W3049162470 cites W2156145961 @default.
- W3049162470 cites W2160088494 @default.
- W3049162470 cites W2171154436 @default.
- W3049162470 cites W2171461890 @default.
- W3049162470 cites W2179179825 @default.
- W3049162470 cites W2234071502 @default.
- W3049162470 cites W2254132687 @default.
- W3049162470 cites W2257061176 @default.
- W3049162470 cites W2336895124 @default.
- W3049162470 cites W2345838610 @default.
- W3049162470 cites W2466451466 @default.
- W3049162470 cites W2481215053 @default.
- W3049162470 cites W2535158955 @default.
- W3049162470 cites W2536536937 @default.
- W3049162470 cites W2549481046 @default.
- W3049162470 cites W2561156916 @default.
- W3049162470 cites W2564768321 @default.
- W3049162470 cites W2577007969 @default.
- W3049162470 cites W2588225708 @default.
- W3049162470 cites W2754877046 @default.
- W3049162470 cites W2759963646 @default.
- W3049162470 cites W2760410509 @default.
- W3049162470 cites W2762192011 @default.
- W3049162470 cites W2768429453 @default.
- W3049162470 cites W2772342845 @default.
- W3049162470 cites W2786816161 @default.
- W3049162470 cites W2805755501 @default.
- W3049162470 cites W2808896902 @default.
- W3049162470 cites W2809211230 @default.
- W3049162470 cites W2811140989 @default.
- W3049162470 cites W2887292818 @default.
- W3049162470 cites W2891536507 @default.
- W3049162470 cites W2894717949 @default.
- W3049162470 cites W2895782973 @default.
- W3049162470 cites W2896438236 @default.
- W3049162470 cites W2900931608 @default.
- W3049162470 cites W2903486314 @default.
- W3049162470 cites W2904477283 @default.
- W3049162470 cites W2904906660 @default.
- W3049162470 cites W2912454954 @default.
- W3049162470 cites W2922375500 @default.
- W3049162470 cites W2944262931 @default.
- W3049162470 cites W2945674342 @default.
- W3049162470 cites W2947706938 @default.
- W3049162470 cites W2951530707 @default.
- W3049162470 cites W2997028447 @default.
- W3049162470 cites W2997720498 @default.
- W3049162470 cites W3000398809 @default.
- W3049162470 cites W3005370270 @default.
- W3049162470 cites W3008185947 @default.
- W3049162470 cites W3011654019 @default.
- W3049162470 cites W3013446577 @default.
- W3049162470 cites W3026221421 @default.
- W3049162470 doi "https://doi.org/10.1016/j.critrevonc.2020.103066" @default.
- W3049162470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32853883" @default.